agxАндрология и генитальная хирургияAndrology and Genital Surgery2070-97812412-8902MedINK Publishing House LLC10.62968/2070-9781-2024-25-1-40-48agx-734Research ArticleОБЗОРНАЯ СТАТЬЯREVIEWРоль цинка в здоровой предстательной железе и при хроническом простатитеThe role of zinc in a healthy prostate gland and in chronic prostatitisБратчиковО. И.BratchikovO. I.

Олег Иванович Братчиков – заведующий кафедрой, доктор медицинских наук, профессор, академик РАЕН, заслуженный врач РФ

305041, Курск, ул. К. Маркса, 3 

Bratchikov Oleg Ivanovich – Head of the Department of Urology, Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Natural Sciences, Honored Doctor of the Russian Federation

3 K. Marx St., Kursk, 305041 

bratov45@mail.ruТюзиковИ. А.TyuzikovI. A.

Игорь Адамович Тюзиков – врач уролог-андролог, кандидат медицинских наук, профессор Российской академии естествознания (РАЕ)

150000, Ярославль, Первомайский пер., 3в 

Tyuzikov Igor Adamovich – urologist–andrologist, Candidate of Medical Sciences, Professor of the Russian Academy of Natural History (RANH)

3–V Pervomaiskiy Ln., Yaroslavl, 150000

phoenix-67@list.ruГрековЕ. А.GrekovE. A.

Евгений Александрович Греков – врач уролог-андролог, эндокринолог, главный врач 

123022, Москва, улица 1905 года, 23 

Grekov Evgeniy Alexandrovich – urologist-andrologist, endocrinologist, Chief Physician 

23 1905 Goda St., Moscow, 123022

gea84@bk.ruНовиковА. В.NovikovA. V.

Алексей Викторович Новиков – доцент кафедры урологии, доктор медицинских наук

РИНЦ AuthorID: 681361

305041, Курск, ул. К. Маркса, 3 

Novikov Alexey Victorovich – Associated professor of the Department of Urology 

РИНЦ AuthorID: 681361 

23 1905 Goda St., Moscow, 123022

ФГБОУ ВО «Курский государственный медицинский университет»РоссияKursk State Medical UniversityRussian FederationМедицинский центр «Тандем-Плюс»РоссияMedical Center Tandem-PlusRussian FederationКлиника Hormone LifeРоссияClinic Hormone LifeRussian FederationФГБОУ ВО «Курский государственный медицинский университет»РоссияClinic Hormone LifeRussian Federation2024080520242514048Copyright © Братчиков О.И., Тюзиков И.А., Греков Е.А., Новиков А.В., 20242024Братчиков О.И., Тюзиков И.А., Греков Е.А., Новиков А.В.Bratchikov O.I., Tyuzikov I.A., Grekov E.A., Novikov A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://agx.elpub.ru/jour/article/view/734

В обзорной статье рассматриваются современные аспекты физиологической роли цинка в предстательной железе, а также последствия для предстательной железы дефицита этого одного из важнейших витальных микроэлементов. Подробно освещены механизмы внутриклеточного транспорта цинка, а также различные физиологические процессы в ткани предстательной железы, требующие обязательного присутствия цинка. В отдельном разделе литературного обзора представлена современная доказательная база взаимосвязи дефицита цинка в предстательной железе с хроническим простатитом и суммированы результаты современных исследований, показывающих необходимость проведения заместительной терапии цинком в рамках комплексной фармакотерапии хронических простатитов, протекающих на фоне дефицита цинка.

The review article discusses modern aspects of the physiological role of zinc in the prostate gland, as well as the consequences for the prostate gland of deficiency of this one of the most important vital trace elements. The mechanisms of intracellular zinc transport, as well as various physiological processes in prostate tissue requiring the mandatory presence of zinc, are covered in more detail. In a separate section of the literature review, the modern evidence base of the relationship of zinc deficiency in the prostate gland with chronic prostatitis is presented and the results of modern studies showing the need for zinc replacement therapy in the framework of complex pharmacotherapy of chronic prostatitis occurring against the background of zinc deficiency are summarized.

цинкдефицит цинкапредстательная железаокислительный стрессцинк–пептидный простатический комплексантиоксидантысупероксиддисмутазаzinczinc deficiencyprostate glandoxidative stresszinc–peptide prostatic complexantioxidantssuperoxide dismutaseReferencesСаяпина И.Ю., Целуйко С.С., Чередниченко О.А. Биологическая роль цинка в предстательной железе (молекулярные аспекты). Дальневосточный медицинский журнал. 2015;2: 137–43.Sayapina I.YU., Celujko S.S., CHerednichenko O.A. Biologicheskaya rol’ cinka v predstatel’noj zheleze (molekulyarnye aspekty). Dal’nevostochnyj medicinskij zhurnal = Far Eastern Medi J. 2015;2: 137–43. (in Russ.)Hennigar S.R., Kelleher S.L. Zinc networks: the cell-specific compartmentalization of zinc for specialized functions. Biol Chem. 2012;393(7):565–78. DOI: 10.1515/hsz-2012-0128.Hennigar S.R., Kelleher S.L. Zinc networks: the cell-specific compartmentalization of zinc for specialized functions. Biol Chem. 2012;393(7):565–78. DOI: 10.1515/hsz-2012-0128.Miyata S. Zinc deficiency in the elderly. Nihon Ronen Igakkai Zasshi. 2007;44(6):677–89. PMID:18200755.Miyata S. Zinc deficiency in the elderly. Nihon Ronen Igakkai Zasshi. 2007;44(6):677–89. PMID:18200755.Rahmati M., Safdarian F., Zakeri M., Zare S. The prevalence of zinc deficiency in 6-month to 12-year old children in Bandar Abbas in 2013. Electron Physician. 2017;9(8):5088–91. DOI: 10.19082/5088.Rahmati M., Safdarian F., Zakeri M., Zare S. The prevalence of zinc deficiency in 6-month to 12-year old children in Bandar Abbas in 2013. Electron Physician. 2017;9(8):5088–91. DOI: 10.19082/5088.Jung A., Spira D., Steinhagen-Thiessen E. et al. Zinc Deficiency Is associated With Depressive Symptoms-Results From the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2017;72(8):1149–54. DOI: 10.1093/gerona/glw218.Jung A., Spira D., Steinhagen-Thiessen E. et al. Zinc Deficiency Is associated With Depressive Symptoms-Results From the Berlin Aging Study II. J Gerontol A Biol Sci Med Sci. 2017;72(8):1149–54. DOI: 10.1093/gerona/glw218.Braun L.A., Ou R., Kure C. et al. Prevalence of Zinc Deficiency in Cardiac Surgery Patients. Heart Lung Circ. 2017 Aug 14. pii: S1443- 9506(17)31342-2. DOI: 10.1016/j.hlc.2017.07.009.Braun L.A., Ou R., Kure C. et al. Prevalence of Zinc Deficiency in Cardiac Surgery Patients. Heart Lung Circ. 2017 Aug 14. pii: S1443- 9506(17)31342-2. DOI: 10.1016/j.hlc.2017.07.009.Cembranel F., González-Chica D.A., d’Orsi E. Inadequate dietary micronutrient intake in men and women in southern Brazil: the EpiFloripa Adults Study, 2012. Cad Saude Publica. 2016; 32(8): e00164015. DOI: 10.1590/0102-311X00164015.Cembranel F., González-Chica D.A., d’Orsi E. Inadequate dietary micronutrient intake in men and women in southern Brazil: the EpiFloripa Adults Study, 2012. Cad Saude Publica. 2016; 32(8): e00164015. DOI: 10.1590/0102-311X00164015.Rotter I., Kosik-Bogacka D.I., Dołęgowska B. et al. Analysis of the relationship between the blood concentration of several metals, macro- and micronutrients and endocrine disorders associated with male aging. Environ Geochem Health. 2016;38(3):749–61. DOI: 10.1007/s10653-015-9758-0.Rotter I., Kosik-Bogacka D.I., Dołęgowska B. et al. Analysis of the relationship between the blood concentration of several metals, macro- and micronutrients and endocrine disorders associated with male aging. Environ Geochem Health. 2016;38(3):749–61. DOI: 10.1007/s10653-015-9758-0.Owen, D.H., Katz, D.F. A review of the physical and chemical prop-erties of human semen and the formulation of a semen simulant. J. Androl. 2005; 26: 459–69]. DOI: 10.2164/jandrol.04104.Owen, D.H., Katz, D.F. A review of the physical and chemical prop-erties of human semen and the formulation of a semen simulant. J. Androl. 2005; 26: 459–69]. DOI: 10.2164/jandrol.04104.Marconi M., Pilatz A., Wagenlehner F. et al. Impact of infection on the secretory capacity of the male accessoryglands. Int. Braz. J. Urol.2009; 35: 299–308, discussion 308-309. DOI: 10.1590/s1677-55382009000300006.Marconi M., Pilatz A., Wagenlehner F. et al. Impact of infection on the secretory capacity of the male accessoryglands. Int. Braz. J. Urol.2009; 35: 299–308, discussion 308-309. DOI: 10.1590/s1677-55382009000300006.Costello L.C., Franklin R.B, Feng P. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion. 2005; 5 (3): 143–53. DOI: 10.1016/j.mito.2005.02.001.Costello L.C., Franklin R.B, Feng P. Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion. 2005; 5 (3): 143–53. DOI: 10.1016/j.mito.2005.02.001.Sorensen M.B., Stoltenberg M., Danscher G., Ernst E. Chelation of intracellular zinc ions affects human sperm cell motility. Mol Hum Reprod. 1999; 5: 338–41. DOI: 10.1093/molehr/5.4.338.Sorensen M.B., Stoltenberg M., Danscher G., Ernst E. Chelation of intracellular zinc ions affects human sperm cell motility. Mol Hum Reprod. 1999; 5: 338–41. DOI: 10.1093/molehr/5.4.338.Yoshida K., Kawano N., Yoshiike M. et al. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans. Mol Hum Reprod. 2008;14: 151–6. DOI: 10.1093/molehr/gan003.Yoshida K., Kawano N., Yoshiike M. et al. Physiological roles of semenogelin I and zinc in sperm motility and semen coagulation on ejaculation in humans. Mol Hum Reprod. 2008;14: 151–6. DOI: 10.1093/molehr/gan003.Elzanaty S. Association between age and epididymal and accessory sex gland function and their relation to sperm motility. Arch Androl. 2007; 53:149–56. DOI: 10.1080/01485010701225667.Elzanaty S. Association between age and epididymal and accessory sex gland function and their relation to sperm motility. Arch Androl. 2007; 53:149–56. DOI: 10.1080/01485010701225667.Iguchi K., Morihara N., Usui S. et al. Castration- and aging-induced changes in the expression of zinс transporter and metallothionein in rat prostate. J Androl. 2011; 32(2):144–50. DOI: 10.2164/jandrol.110.011205.Iguchi K., Morihara N., Usui S. et al. Castration- and aginginduced changes in the expression of zinс transporter and metallothionein in rat prostate. J Androl. 2011; 32(2):144–50. DOI: 10.2164/jandrol.110.011205.Guo L., Lichten L.A., Ryu M.S. et al. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc Natl Acad Sci USA. 2010; 107:2818–23. DOI: 10.1073/pnas.0914941107.Guo L., Lichten L.A., Ryu M.S. et al. STAT5-glucocorticoid receptor interaction and MTF-1 regulate the expression of ZnT2 (Slc30a2) in pancreatic acinar cells. Proc Natl Acad Sci USA. 2010; 107:2818–23. DOI: 10.1073/pnas.0914941107.Chen Q.G. Zhang Z., Yang Q., et al. The role of zinc transporter ZIP 4 in prostate carcinoma. Urol. Oncol. 2012; 30 (6): 906–11. DOI: 10.1016/j.urolonc.2010.11.010.Chen Q.G. Zhang Z., Yang Q., et al. The role of zinc transporter ZIP 4 in prostate carcinoma. Urol. Oncol. 2012; 30 (6): 906–11. DOI: 10.1016/j.urolonc.2010.11.010.Desouki M.M., Geradts J., Milon B. et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol. Cancer. 2007; 6: 37. DOI: 10.1186/1476-4598-6-37.Desouki M.M., Geradts J., Milon B. et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol. Cancer. 2007; 6: 37. DOI: 10.1186/1476-4598-6-37.Ding W.Q., Lind S.E. Metal ionophores – an emerging class of anticancer drugs. IUBMB Life. 2009; 61: 1013–8. DOI: 10.1002/iub.253.Ding W.Q., Lind S.E. Metal ionophores – an emerging class of anticancer drugs. IUBMB Life. 2009; 61: 1013–8. DOI: 10.1002/iub.253.Huang L., Kirschke C.P., Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006; 6 (10): 1–13. DOI: 10.1186/1475-2867-6-10.Huang L., Kirschke C.P., Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006; 6 (10): 1–13. DOI: 10.1186/1475-2867-6-10.Johnson L.A., Kanak M.A., Kajdacsy-Balla A. et al. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods. 2010; 52: 316–21. DOI: 10.1016/j.ymeth.2010.08.004.Johnson L.A., Kanak M.A., Kajdacsy-Balla A. et al. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods. 2010; 52: 316–21. DOI: 10.1016/j.ymeth.2010.08.004.Iguchi K., Otsuka T., Usui S. et al. Correlation between ZIP2 messenger RNA expression and zinc level in rat lateral prostate. Biol Trace Elem Res. 2006; 112: 159–67. DOI: 10.1385/BTER:112:2:159.Iguchi K., Otsuka T., Usui S. et al. Correlation between ZIP2 messenger RNA expression and zinc level in rat lateral prostate. Biol Trace Elem Res. 2006; 112: 159–67. DOI: 10.1385/BTER:112:2:159.Franklin R.B., Feng P., Milon B. et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005; 4:32–45. DOI: 10.1186/1476-4598-4-32.Franklin R.B., Feng P., Milon B. et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol Cancer. 2005; 4:32–45. DOI: 10.1186/1476-4598-4-32.Guerinot M.L. The ZIP family of metal transporters. Biochim Biophys Acta. 2000;1465 (1–2): 190–8. DOI: 10.1016/s0005-2736(00)00138-3.Guerinot M.L. The ZIP family of metal transporters. Biochim Biophys Acta. 2000;1465 (1–2): 190–8. DOI: 10.1016/s0005-2736(00)00138-3.Kambe T., Yamaguchi-Iwai Y., Sasaki R. et al. Overview of mammalian zinc transporters. Cell. Mol. Life Sci. 2004; 61: 49–68. DOI: 10.1007/s00018-003-3148- г.Kambe T., Yamaguchi-Iwai Y., Sasaki R. et al. Overview of mammalian zinc transporters. Cell. Mol. Life Sci. 2004; 61: 49–68. DOI: 10.1007/s00018-003-3148- г.Kirschke C.P., Huang L. Expression of the ZNT (SLC30) family members in the epithelium of the mouse prostate during sexual maturation. J Mol Histol. 2008; 39:359–70. DOI: 10.1007/s10735-008-9174-1.Kirschke C.P., Huang L. Expression of the ZNT (SLC30) family members in the epithelium of the mouse prostate during sexual maturation. J Mol Histol. 2008; 39:359–70. DOI: 10.1007/s10735-008-9174-1.Fujimoto N., Akimoto Y., Suzuki T. et al. Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J Endocrinol. 2006; 190: 793–803. DOI: 10.1677/joe.1.06733.Fujimoto N., Akimoto Y., Suzuki T. et al. Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J Endocrinol. 2006; 190: 793–803. DOI: 10.1677/joe.1.06733.Ishihara K., Yamazaki T., Ishida Y. et al. Zinc transport complexes contribute to the homeostatic maintenance of secretory pathway function in vertebrate cells. J Biol Chem. 2006; 281:17743–50. DOI: 10.1074/jbc.M602470200.Ishihara K., Yamazaki T., Ishida Y. et al. Zinc transport complexes contribute to the homeostatic maintenance of secretory pathway function in vertebrate cells. J Biol Chem. 2006; 281:17743–50. DOI: 10.1074/jbc.M602470200.Ellis C.D., Macdiarmid C.W., Eide D.J. Heteromeric protein complexes mediate zinc transport into the secretory pathway of eukaryotic cells. J Biol Chem. 2005; 280:28811–8. DOI: 10.1074/jbc.M505500200.Ellis C.D., Macdiarmid C.W., Eide D.J. Heteromeric protein complexes mediate zinc transport into the secretory pathway of eukaryotic cells. J Biol Chem. 2005; 280:28811–8. DOI: 10.1074/jbc.M505500200.Fukunaka A., Suzuki T., Kurokawa Y. et al. Demonstration and characterization of the heterodimerization of ZnT5 and ZnT6 in the early secretory pathway. J Biol Chem. 2009; 284:30798–806. DOI: 10.1074/jbc.M109.026435.Fukunaka A., Suzuki T., Kurokawa Y. et al. Demonstration and characterization of the heterodimerization of ZnT5 and ZnT6 in the early secretory pathway. J Biol Chem. 2009; 284:30798–806. DOI: 10.1074/jbc.M109.026435.McCormick N., Velasquez V., Finney L. et al. X-ray fluorescence microscopy reveals accumulation and secretion of discrete intracellular zinc pools in the lactating mouse mammary gland. PLoS ONE. 2010;5: e11078. DOI:10.1371/journal.pone.0011078.McCormick N., Velasquez V., Finney L. et al. X-ray fluorescence microscopy reveals accumulation and secretion of discrete intracellular zinc pools in the lactating mouse mammary gland. PLoS ONE. 2010;5: e11078. DOI:10.1371/journal.pone.0011078.Kelleher S.L., McCormick N.H., Velasquez V., Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr. 2011; 2(2):101–11. DOI: 10.3945/an.110.000232.Kelleher S.L., McCormick N.H., Velasquez V., Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv Nutr. 2011; 2(2):101–11. DOI: 10.3945/an.110.000232.Costello L.C., Franklin R.B. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate. 1998; 35:285–96. DOI: 10.1002/(sici)1097-0045(19980601)35:4<285::aid-pros8>3.0.co;2-f.Costello L.C., Franklin R.B. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate. 1998; 35:285–96. DOI: 10.1002/(sici)1097-0045(19980601)35:4<285::aid-pros8>3.0.co;2-f.Costello L.C., Franklin R.B. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert. Rev. Anticancer Ther. 2012; 12 (1): 121–8. DOI: 10.1586/era.11.190.Costello L.C., Franklin R.B. Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity. Expert. Rev. Anticancer Ther. 2012; 12 (1): 121–8. DOI: 10.1586/era.11.190.Costello L.C., Franklin R.B. Zinc is decreased in prostate cancer: an established relationship of prostate cancer. J. Biol. Inorg. Chem. 2011;16 (1): 3–8. DOI: 10.1007/s00775-010-0736-9.Costello L.C., Franklin R.B. Zinc is decreased in prostate cancer: an established relationship of prostate cancer. J. Biol. Inorg. Chem. 2011;16 (1): 3–8. DOI: 10.1007/s00775-010-0736-9.Liu Y., Franklin R.B., Costello L.C. Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate. 1997; 30:26–32. DOI: 10.1002/(sici)1097-0045(19970101)30:1<26:: aid-pros4>3.0.co;2-j.Liu Y., Franklin R.B., Costello L.C. Prolactin and testosterone regulation of mitochondrial zinc in prostate epithelial cells. Prostate. 1997; 30:26–32. DOI: 10.1002/(sici)1097-0045(19970101)30:1<26:: aid-pros4>3.0.co;2-j.Kolenko V., Teper E., Kutikov A. et al. Zinc and zinc transporters in prostate carcinogenesis. Nat. Rev. Urol. 2013;10 (4): 219–226. DOI: 10.1038/nrurol.2013.43.Kolenko V., Teper E., Kutikov A. et al. Zinc and zinc transporters in prostate carcinogenesis. Nat. Rev. Urol. 2013;10 (4): 219–226. DOI: 10.1038/nrurol.2013.43.Singh K.K., Desouki M.M., Franklin R.B. et al. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer. 2006; 5: 14. DOI: 10.1186/1476-4598-5-14.Singh K.K., Desouki M.M., Franklin R.B. et al. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol. Cancer. 2006; 5: 14. DOI: 10.1186/1476-4598-5-14.Franz M.C., Anderle P., Bürzle M. et al. Zinc transporters in prostate cancer. Mol. Aspects Med. 2013; 34 (2–3):735–41. DOI: 10.1016/j.mam.2012.11.007.Franz M.C., Anderle P., Bürzle M. et al. Zinc transporters in prostate cancer. Mol. Aspects Med. 2013; 34 (2–3):735–41. DOI: 10.1016/j.mam.2012.11.007.Golovine K., Uzzo R.G., Makhov P. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate. 2008; 68 (13):1443–9. DOI: 10.1002/pros.20810.Golovine K., Uzzo R.G., Makhov P. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate. 2008; 68 (13):1443–9. DOI: 10.1002/pros.20810.Ku J.H., Seo S.Y., Kwak C. et al. The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells. Urol. Oncol. 2012;30 (5): 562–8. DOI: 10.1016/j.urolonc.2010.06.001.Ku J.H., Seo S.Y., Kwak C. et al. The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells. Urol. Oncol. 2012;30 (5): 562–8. DOI: 10.1016/j.urolonc.2010.06.001.Zaichick V.Y., Sviridova T.V., Zaichick S.V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol. 1997;29: 565–74. DOI: 10.1007/BF02552202.Zaichick V.Y., Sviridova T.V., Zaichick S.V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int Urol Nephrol. 1997;29: 565–74. DOI: 10.1007/BF02552202.Zaichick V.Y., Sviridova T.V., Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol. 1996; 28:687–94. DOI: 10.1007/BF02552165.Zaichick V.Y., Sviridova T.V., Zaichick SV. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int Urol Nephrol. 1996; 28:687–94. DOI: 10.1007/BF02552165.Feng P., Li T., Guan Z. et al. The involvement of Bax in zincinduced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer. 2008;7: 25–30. DOI: 10.1186/1476-4598-7-25.Feng P., Li T., Guan Z. et al. The involvement of Bax in zincinduced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer. 2008;7: 25–30. DOI: 10.1186/1476-4598-7-25.Franklin R.B., Costello L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463: 211–7. DOI: 10.1016/j.abb.2007.02.033.Franklin R.B., Costello L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys. 2007;463: 211–7. DOI: 10.1016/j.abb.2007.02.033.Bianchi-Frias D., Vakar-Lopez F., Coleman I.M. et al. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS ONE. 2010; 5:12501–16. DOI: 10.1371/journal.pone.0012501.Bianchi-Frias D., Vakar-Lopez F., Coleman I.M. et al. The effects of aging on the molecular and cellular composition of the prostate microenvironment. PLoS ONE. 2010; 5:12501–16. DOI: 10.1371/journal.pone.0012501.Song Y., Elias V., Loban A. et al. Marginal zinc deficiency increases oxidative DNA damage in the prostate after chronic exercise. Free Radic Biol Med. 2010; 48:82–8. DOI: 10.1016/j.freeradbiomed.2009.10.030.Song Y., Elias V., Loban A. et al. Marginal zinc deficiency increases oxidative DNA damage in the prostate after chronic exercise. Free Radic Biol Med. 2010; 48:82–8. DOI: 10.1016/j.freeradbiomed.2009.10.030.Yan M., Song Y., Wong C.P. et al. Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr. 2008;138: 667–73. DOI: 10.1093/jn/138.4.667.Yan M., Song Y., Wong C.P. et al. Zinc deficiency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr. 2008;138: 667–73. DOI: 10.1093/jn/138.4.667.Golovine K., Makhov P., Uzzo R.G. et al. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappa B and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin. Cancer Res. 2008; 14: 5376–84. DOI: 10.1158/1078-0432.CCR-08-0455.Golovine K., Makhov P., Uzzo R.G. et al. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappa B and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin. Cancer Res. 2008; 14: 5376–84. DOI: 10.1158/1078-0432.CCR-08-0455.Uzzo R.G. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006; 27:1980–90. DOI: 10.1093/carcin/bgl034.Uzzo R.G. Diverse effects of zinc on NF-kappaB and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006; 27:1980–90. DOI: 10.1093/carcin/bgl034.Ku J.H., Seo S.Y., Kwak C. et al. The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells. Urol. Oncol. 2012; 30 (5): 562–8. DOI: doi: 10.1016/j.urolonc.2010.06.001.Ku J.H., Seo S.Y., Kwak C. et al. The role of survivin and Bcl-2 in zinc-induced apoptosis in prostate cancer cells. Urol. Oncol. 2012; 30 (5): 562–8. DOI: doi: 10.1016/j.urolonc.2010.06.001.Zhao J., Wu Q., Hu X. et al. Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis. Sci Rep. 2016; 6: 25778. DOI: 10.1038/srep25778.Zhao J., Wu Q., Hu X. et al. Comparative study of serum zinc concentrations in benign and malignant prostate disease: A Systematic Review and Meta-Analysis. Sci Rep. 2016; 6: 25778. DOI: 10.1038/srep25778.Cui D., Han G., Shang Y. et al. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31(9):1763–9. DOI: 10.1185/03007995.2015.1072707.Cui D., Han G., Shang Y. et al. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis. Curr Med Res Opin. 2015;31(9):1763–9. DOI: 10.1185/03007995.2015.1072707.Gumulec J., Masarik M., Adam V. et al. Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS One. 2014;9(6): e99790. DOI: 10.1371/journal.pone.0099790.Gumulec J., Masarik M., Adam V. et al. Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS One. 2014;9(6): e99790. DOI: 10.1371/journal.pone.0099790.Mahmoud A.M., Al-Alem U, Dabbous F. et al. Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis. PLoS One. 2016;11(11): e0165956. DOI: 10.1371/journal.pone0165956.Mahmoud A.M., Al-Alem U, Dabbous F. et al. Zinc Intake and Risk of Prostate Cancer: Case-Control Study and Meta-Analysis. PLoS One. 2016;11(11): e0165956. DOI: 10.1371/journal.pone0165956.Fair W.R., Couch J., Wehner N. Prostatic antibacterial factor. Identity and significance. Urology. 1976; 7:169–77. DOI: 10.1016/0090-4295(76)90305-8.Fair W.R., Couch J., Wehner N. Prostatic antibacterial factor. Identity and significance. Urology. 1976; 7:169–77. DOI: 10.1016/0090-4295(76)90305-8.Mårdh P.A., Colleen S. Antimicrobial activity of human seminal fluid. Scand J Urol Nephrol. 1975;9(1):17–23. DOI: 10.3109/00365597509139907.Mårdh P.A., Colleen S. Antimicrobial activity of human seminal fluid. Scand J Urol Nephrol. 1975;9(1):17–23. DOI: 10.3109/00365597509139907.Colleen S., Mårdh P.A., Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol. 1975;9(3):192–7. DOI: 10.3109/00365597509134210.Colleen S., Mårdh P.A., Schytz A. Magnesium and zinc in seminal fluid of healthy males and patients with non-acute prostatitis with and without gonorrhoea. Scand J Urol Nephrol. 1975;9(3):192–7. DOI: 10.3109/00365597509134210.Canale D., Bartelloni M., Negroni A. et al. Zinc in human semen. Int J Androl. 1986;9(6):477–80. DOI: 10.1111/j.1365-2605.1986tb00909.x.Canale D., Bartelloni M., Negroni A. et al. Zinc in human semen. Int J Androl. 1986;9(6):477–80. DOI: 10.1111/j.1365-2605.1986tb00909.x.Neal D.E.Jr., Kaack M.B., Fussell E.N., Roberts J.A. Changes in seminal fluid zinc during experimental prostatitis. Urol Res. 1993;21(1):71–4. DOI: 10.1007/BF00295197.Neal D.E.Jr., Kaack M.B., Fussell E.N., Roberts J.A. Changes in seminal fluid zinc during experimental prostatitis. Urol Res. 1993;21(1):71–4. DOI: 10.1007/BF00295197.Mo L.J., Chen X., Wang X.M. et al. Reduced zinc concentration in expressed prostatic secretion relates to the pain symptoms of types III and IV prostatitis. Zhonghua Nan Ke Xue. 2016;22(6):496–500. PMID: 28963836.Mo L.J., Chen X., Wang X.M. et al. Reduced zinc concentration in expressed prostatic secretion relates to the pain symptoms of types III and IV prostatitis. Zhonghua Nan Ke Xue. 2016;22(6):496–500. PMID: 28963836.Gómez Y., Arocha F., Espinoza F. et al. Zinc levels in prostatic fluid of patients with prostate pathologies. Invest Clin. 2007;48(3):287–94. PMID: 17853788.Gómez Y., Arocha F., Espinoza F. et al. Zinc levels in prostatic fluid of patients with prostate pathologies. Invest Clin. 2007;48(3):287–94. PMID: 17853788.Roumeguère T., Sfeir J., El Rassy E. et al. Oxidative stress and prostatic diseases. Mol Clin Oncol. 2017;7(5):723–8. DOI: 10.389/mco.2017.1413.Roumeguère T., Sfeir J., El Rassy E. et al. Oxidative stress and prostatic diseases. Mol Clin Oncol. 2017;7(5):723–8. DOI: 10.389/mco.2017.1413.Kaya E., Ozgok Y., Zor M. et al. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study. Adv Clin Exp Med. 2017;26(7):1095–9. DOI: 10.17219acem/66837.Kaya E., Ozgok Y., Zor M. et al. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study. Adv Clin Exp Med. 2017;26(7):1095–9. DOI: 10.17219acem/66837.Xiong Y., Qiu X., Shi W. et al. Anti-inflammatory and antioxidant effect of modified Bazhengsan in a rat model of chronic bacterial prostatitis. J Ethnopharmacol. 2017;198:73–80. DOI: 10.101/j.jep.2016.12.039.Xiong Y., Qiu X., Shi W. et al. Anti-inflammatory and antioxidant effect of modified Bazhengsan in a rat model of chronic bacterial prostatitis. J Ethnopharmacol. 2017;198:73–80. DOI: 10.101/j.jep.2016.12.039.Hu Y., Niu X., Wang G. et al. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model. Androl. 2016;4(6):1209–16. DOI: 10.1111/andr.12273.Hu Y., Niu X., Wang G. et al. Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model. Androl. 2016;4(6):1209–16. DOI: 10.1111/andr.12273.Goodarzi D., Cyrus A., Baghinia M.R. et al. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013;45(4):259–64. PMID: 24448329.Goodarzi D., Cyrus A., Baghinia M.R. et al. The efficacy of zinc for treatment of chronic prostatitis. Acta Med Indones. 2013;45(4):259–64. PMID: 24448329.Condorelli R.A., Russo G.I., Calogero A.E. et al. Chronic prostatitis and its detrimental impact on sperm parameters: a systematic review and meta-analysis. J Endocrinol Invest. 2017;40(11):1209–18. DOI: doi: 10.1007/s40618-017-0684-0.Condorelli R.A., Russo G.I., Calogero A.E. et al. Chronic prostatitis and its detrimental impact on sperm parameters: a systematic review and meta-analysis. J Endocrinol Invest. 2017;40(11):1209–18. DOI: doi: 10.1007/s40618-017-0684-0.

The authors declare that there are no conflicts of interest present.